Position in EXEL
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$21,480,143
-$536,623 QoQ
Shares Held
394,783
-23.1% QoQ
Ownership
0.159%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#88
of 756 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VICTORY CAPITAL MANAGEMENT INC holds $2,534,997,913 across 158 Biotechnology names. EXEL ranks #18 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,173,152 | $1,079,469,792 | |
| 2 | RPRX |
Royalty Pharma plc
|
3,682,932 | $206,501,997 | |
| 3 | INCY |
Incyte Corp
|
1,480,342 | $167,811,569 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
686,719 | $165,478,677 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
253,764 | $80,212,262 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
126,343 | $78,779,914 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
172,842 | $52,030,627 | |
| 8 | BNTX |
BioNTech SE
|
539,787 | $50,227,180 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,480,143 | 394,783 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $22,016,766 | 513,331 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $19,317,502 | 440,737 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $21,770,675 | 527,135 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $14,991,652 | 340,101 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $12,703,876 | 344,092 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $2,785,545 | 83,650 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $3,533,819 | 136,178 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $2,624,630 | 116,806 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $2,407,123 | 101,438 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $3,136,236 | 130,731 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,230,613 | 56,321 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $1,058,579 | 55,394 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $1,075,566 | 55,413 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $1,224,942 | 76,368 | Shares | Sole | 2023-04-25 | |
| 2022-09-30 | $1,780,134 | 113,529 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $2,368,254 | 113,749 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $2,588,891 | 114,199 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $1,156,758 | 63,280 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $1,209,842 | 57,230 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $1,442,750 | 79,185 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $2,287,824 | 101,276 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $4,173,476 | 207,946 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $5,789,808 | 236,802 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $3,329,606 | 140,253 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $2,406,322 | 139,740 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||